1 – 10 of 206
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Cancellation of klystron-induced energy and arrival-time variations in linear accelerators with arc-type bunch compressors
(
- Contribution to journal › Article
-
Mark
Constitutional Factors and Irradiation as Risk Factors for Thymoma : A European Case–Control Study
(
- Contribution to journal › Article
-
Mark
Low-dose tamoxifen treatment reduces collagen organisation indicative of tissue stiffness in the normal breast : results from the KARISMA randomised controlled trial
(
- Contribution to journal › Article
-
Mark
Transcriptomic profiles of myxofibrosarcoma and undifferentiated pleomorphic sarcoma correlate with clinical and genomic features
(
- Contribution to journal › Article
-
Mark
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial
(
- Contribution to journal › Article
-
Mark
Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma : a 10-year follow-up
(
- Contribution to journal › Letter
- 2023
-
Mark
Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts
(
- Contribution to journal › Article
-
Mark
Exposure to phenoxyacetic acids and glyphosate as risk factors for non-Hodgkin lymphoma– pooled analysis of three Swedish case-control studies including the sub-type hairy cell leukemia
(
- Contribution to journal › Article
-
Mark
Side effects of low-dose tamoxifen : results from a six-armed randomised controlled trial in healthy women
(
- Contribution to journal › Article
-
Mark
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
(
- Contribution to journal › Article